Swiss pharmaceutical company Novartis this week lost a seven-year legal battle over a drug patent in India. It’s certainly a win for those in India who use the drug, and for patients in India more generally…
- Associate Professor Politics and Policy Studies, Deakin University
India is the global focal point for legal and political struggles over patent rights and access to medicines. Particular attention is focused on the Swiss pharmaceutical giant Novartis, which is in battle…
New medicines must be approved as safe, efficacious and of good quality before they can be prescribed. But authors of two recent articles in the British Medical Journal argue that governments should introduce…
Two large multinational pharmaceutical companies are fighting for patents and monopoly pricing in Indian courts. The outcomes of the cases – involving Novartis and Bayer – are likely to determine the country’s…
Contact Hans for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Deakin University, Melbourne
- Article Feed
- Joined
